Physician profile
Ya-Ting Chen
NPI 1982095535
$4,416.57
in general payments reported to CMS, 2019-2025
10 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,174 · 2023: $879 · 2024: $302 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635 · Travel and Lodging: $538 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.34 |
| Travel and Lodging | $537.71 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,075.38 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Nevro Corp. | $294.88 | 2022-2024 | Senza |
| Spr Therapeutics, INC | $269.81 | 2022-2023 | Sprint Pns System |
| Stratus Medical, LLC | $184.32 | 2025 | Nimbus |
| Relievant Medsystems, INC. | $140.45 | 2022 | |
| Nalu Medical, INC. | $137.32 | 2023 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $127.41 | 2023 | Qutenza |
| Stryker Corporation | $105.00 | 2023 | Spinejack |
| Boston Scientific Corporation | $54.99 | 2022 | |
| Djo, LLC | $27.01 | 2024 | Donjoy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ya-Ting Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.